Morgan Stanley’s bioAffinity Technologies BIAF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29 | Sell |
100
-200
| -67% | -$58 | ﹤0.01% | 7927 |
|
|
2025
Q1 | $78 | Sell |
300
-200
| -40% | -$52 | ﹤0.01% | 7615 |
|
|
2024
Q4 | $455 | Sell |
500
-4,461
| -90% | -$4.06K | ﹤0.01% | 7354 |
|
|
2024
Q3 | $10.3K | Buy |
4,961
+3,961
| +396% | +$8.24K | ﹤0.01% | 6712 |
|
|
2024
Q2 | $2.16K | Buy |
+1,000
| New | +$2.16K | ﹤0.01% | 7053 |
|
|
2023
Q1 | – | Sell |
-3
| Closed | -$5 | – | 7716 |
|
|
2022
Q4 | $5 | Buy |
+3
| New | +$5 | ﹤0.01% | 7830 |
|